LifeMD Deadline: LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm

Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][3]. Group 1: Class Action Details - Investors who bought LifeMD securities between May 7, 2025, and August 5, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 27, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements, including being ranked No. 1 for securities class action settlements in 2017 and recovering over $438 million for investors in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that LifeMD's defendants made materially false and misleading statements regarding the company's competitive position and financial guidance, particularly concerning customer acquisition costs [5]. - It is claimed that these misrepresentations led to investor damages when the true information became public [5].